PPARGC1A and chronic obstructive pulmonary disease: In addition, variation in the expression of the mitochondrial transcription factor TFAM, a downstream effector of PGC1α, and of the complex IV subunit COX1, a target gene of TFAM, tended to be reduced in COPD myotubes compared to healthy muscle cells upon EPS (Figure 5).